Literature DB >> 28979706

The negative regulation of miR-149-5p in melanoma cell survival and apoptosis by targeting LRIG2.

Wenqi Chen1, Jinhai Zhang2, Huijuan Xu1, Jie Dai1, Xiaorong Zhang1.   

Abstract

MicroRNAs (miRNAs) are key regulators of diverse biological processes in tumor progression including melanoma. LRIG2 is reported as an oncogene in cancer, however, little is known regarding the molecular and functions of LRIG2 in melanoma. In this study, we reported that LRIG2 expression was higher in melanoma tissues and cell lines and was regulated by miR-149-5p. Furthermore, a luciferase reporter assay and rescue experiment indicated that miR-149-5p directly targeted LRIG2 by binding its 3'UTR. The overexpression of miR-149-5p significantly suppressed melanoma cell proliferation, colony formation, and promoted cell apoptosis. These results suggest that miR-149-5p acts as a suppressing molecule and may be a good method for melanoma therapy.

Entities:  

Keywords:  LRIG2; apoptosis; cell proliferation; melanoma; miR-149-5p

Year:  2017        PMID: 28979706      PMCID: PMC5622275     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  26 in total

1.  Multimodal tumor suppression by miR-302 cluster in melanoma and colon cancer.

Authors:  Hamid Maadi; Abdolvahab Moshtaghian; Masoumeh Fakhr Taha; Seyed Javad Mowla; Asiye Kazeroonian; Nikolas K Haass; Arash Javeri
Journal:  Int J Biochem Cell Biol       Date:  2016-11-10       Impact factor: 5.085

Review 2.  The LRIG family: enigmatic regulators of growth factor receptor signaling.

Authors:  Catalina Simion; Maria Elvira Cedano-Prieto; Colleen Sweeney
Journal:  Endocr Relat Cancer       Date:  2014-09-02       Impact factor: 5.678

3.  LRIG3 modulates proliferation, apoptosis and invasion of glioblastoma cells as a potent tumor suppressor.

Authors:  Dongsheng Guo; Hongkuan Yang; Yang Guo; Qungen Xiao; Feng Mao; Yihu Tan; Xueyan Wan; Baofeng Wang; Ting Lei
Journal:  J Neurol Sci       Date:  2015-02-14       Impact factor: 3.181

4.  Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival.

Authors:  Camilla Holmlund; Hannu Haapasalo; Wei Yi; Olayinka Raheem; Thomas Brännström; Helena Bragge; Roger Henriksson; Håkan Hedman
Journal:  Neuropathology       Date:  2009-10-20       Impact factor: 1.906

Review 5.  MicroRNAs role as potential biomarkers and key regulators in melanoma.

Authors:  Chiara Varamo; Marcella Occelli; Daniela Vivenza; Marco Merlano; Cristiana Lo Nigro
Journal:  Genes Chromosomes Cancer       Date:  2016-10-25       Impact factor: 5.006

6.  Characterization and tissue-specific expression of human LRIG2.

Authors:  Camilla Holmlund; Jonas Nilsson; Dongsheng Guo; Anna Starefeldt; Irina Golovleva; Roger Henriksson; Håkan Hedman
Journal:  Gene       Date:  2004-05-12       Impact factor: 3.688

7.  MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.

Authors:  Bei-Bei Su; Shu-Wei Zhou; Cai-Bin Gan; Xiao-Ning Zhang
Journal:  J Surg Res       Date:  2016-03-19       Impact factor: 2.192

8.  Soluble LRIG2 ectodomain is released from glioblastoma cells and promotes the proliferation and inhibits the apoptosis of glioblastoma cells in vitro and in vivo in a similar manner to the full-length LRIG2.

Authors:  Qungen Xiao; Yihu Tan; Yang Guo; Hongkuan Yang; Feng Mao; Ruifan Xie; Baofeng Wang; Ting Lei; Dongsheng Guo
Journal:  PLoS One       Date:  2014-10-29       Impact factor: 3.240

9.  LRIG2 expression and prognosis in non-small cell lung cancer.

Authors:  Guangchuan Wang; Jie Wu; Huijuan Song
Journal:  Oncol Lett       Date:  2014-05-19       Impact factor: 2.967

10.  miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways.

Authors:  Xiaoyan Sun; Jun Li; Yanhong Sun; Yi Zhang; Liyun Dong; Chen Shen; Liu Yang; Ming Yang; Yan Li; Guanxin Shen; Yating Tu; Juan Tao
Journal:  Oncotarget       Date:  2016-08-16
View more
  13 in total

Review 1.  MicroRNA heterogeneity in melanoma progression.

Authors:  Anita Thyagarajan; Kenneth Y Tsai; Ravi P Sahu
Journal:  Semin Cancer Biol       Date:  2019-06-01       Impact factor: 15.707

2.  Circ-FOXM1 knockdown suppresses non-small cell lung cancer development by regulating the miR-149-5p/ATG5 axis.

Authors:  Haitao Wei; Li Li; Haifeng Zhang; Feng Xu; Longqi Chen; Guowei Che; Yun Wang
Journal:  Cell Cycle       Date:  2021-01-08       Impact factor: 4.534

Review 3.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

4.  A Novel lncRNA, LINC00460, Affects Cell Proliferation and Apoptosis by Regulating KLF2 and CUL4A Expression in Colorectal Cancer.

Authors:  Yifan Lian; Changsheng Yan; Hongzhi Xu; Jiebin Yang; Yang Yu; Jing Zhou; Yongguo Shi; Jianlin Ren; Guozhong Ji; Keming Wang
Journal:  Mol Ther Nucleic Acids       Date:  2018-07-06       Impact factor: 8.886

5.  miR-149-5p Regulates Goat Hair Follicle Stem Cell Proliferation and Apoptosis by Targeting the CMTM3/AR Axis During Superior-Quality Brush Hair Formation.

Authors:  Jian Wang; Jingwen Qu; Yongjun Li; Yunkui Feng; Jinliang Ma; Liuming Zhang; Changjiang Chu; Huiru Hu; Yanhu Wang; Dejun Ji
Journal:  Front Genet       Date:  2020-11-11       Impact factor: 4.599

6.  Long Non-Coding RNA BLACAT1 Promotes the Tumorigenesis of Gastric Cancer by Sponging microRNA-149-5p and Targeting KIF2A.

Authors:  Zhengkun Wang; Xichun Liu; Xiaolei Liu; Dongguang Niu
Journal:  Cancer Manag Res       Date:  2020-07-30       Impact factor: 3.602

7.  MicroRNA-331 Inhibits Proliferation and Invasion of Melanoma Cells by Targeting Astrocyte-Elevated Gene-1.

Authors:  Li Chen; Guozhang Ma; Xiaohui Cao; Xiaoxia An; Xiguang Liu
Journal:  Oncol Res       Date:  2018-02-17       Impact factor: 5.574

8.  MicroRNA-342 Prohibits Proliferation and Invasion of Melanoma Cells by Directly Targeting Zinc-Finger E-Box-Binding Homeobox 1.

Authors:  Quan Shi; Qi He; Jing Wei
Journal:  Oncol Res       Date:  2018-03-01       Impact factor: 5.574

9.  Hsa-miR-149-5p Suppresses Prostate Carcinoma Malignancy by Suppressing RGS17.

Authors:  Jinhua Ma; Hongbing Wei; Xianlin Li; Xi Qu
Journal:  Cancer Manag Res       Date:  2021-03-25       Impact factor: 3.989

Review 10.  A Review on the Role of miR-149-5p in the Carcinogenesis.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Sepideh Kadkhoda; Mohammad Taheri; Arash Tafrishinejad
Journal:  Int J Mol Sci       Date:  2021-12-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.